Excellagen is clearly a cash cow waiting to happen. As long as the financing deal is structured so that available cash flow is prioritized to paying off this deal before other commitments (which I'm sure is the approach), they should be able to get more reasonable financing offers. Not at 30-year mortgage rates, mind you, but not dealing with sharks. IMHO.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links